Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K, Minakuchi H, Wakino S, Fujimura K, Hasegawa K, Komatsu M, Yoshifuji A, Futatsugi K, Shinozuka K, Washida N, Kanda T, Tokuyama H, Hayashi K, Itoh H.
Hosoya K, et al. Among authors: hayashi k.
Kidney Int. 2015 Apr;87(4):749-60. doi: 10.1038/ki.2014.348. Epub 2014 Oct 22.
Kidney Int. 2015.
PMID: 25337775
Free article.
Clinical Trial.